Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dexamethasone sodium phosphate crystal form and its crystallization preparation method

A technology of dexamethasone sodium phosphate and crystal form, which is applied to the crystal form of dexamethasone sodium phosphate and the field of crystal preparation, can solve the problems affecting product purity, storage time, different heat resistance and the like, achieves high crystallinity, Easy to filter, large particle size effect

Active Publication Date: 2007-05-30
TIANJIN UNIV +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the difference in crystal form has no effect on the efficacy of the drug, it will have a large difference in the heat resistance of the product, which will affect the purity and storage time of the product.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dexamethasone sodium phosphate crystal form and its crystallization preparation method
  • Dexamethasone sodium phosphate crystal form and its crystallization preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Add 120g of dexamethasone phosphate into a three-necked flask, add 2000ml of ethanol and 6g of activated carbon at the same time, stir and dissolve at a constant temperature of 40°C, and filter after continuous stirring for 60 minutes. The filtrate is moved in the crystallizer, and configuration concentration is the sodium hydroxide solution of 100g / L simultaneously. Then sodium hydroxide solution is added into the crystallizer for reaction, and the pH value at the end of the reaction process is controlled at 11.0. Add about 4000 ml of diethyl ether-water mixed solvent to the reacted dexamethasone sodium phosphate solution while stirring at 20° C. to crystallize. After the crystallization is finished, carry out centrifugation, wash with acetone, and dry the obtained crystal product at 70° C. and a pressure of 0.1 MPa for 6 hours, and then dry at this temperature for 15 hours at a pressure of 0.008 MPa. The content of the final crystal product is 99.3%, the quality conf...

Embodiment 2

[0030] Add 12g of dexamethasone phosphate into a three-necked flask, add 120ml of ethanol and 1.2g of activated carbon at the same time, stir and dissolve at a constant temperature of 40°C, and filter after continuous stirring for 30 minutes. The filtrate is moved in the crystallizer, and configuration concentration is the sodium hydroxide solution of 100g / L simultaneously. Then sodium hydroxide solution is added into the crystallizer for reaction, and the pH value at the end of the reaction process is controlled at 10.5. Add about 360 ml of diethyl ether-water mixed solvent to the reacted dexamethasone sodium phosphate solution while stirring at 25° C. for crystallization. Centrifuge after crystallization, wash with ethanol, dry the obtained crystal product at 50° C. and a pressure of 0.1 MPa for 6 hours, and then dry at this temperature for 14 hours at 0.002 MPa. The content of the final crystal product is 99.3%, and the quality conforms to the latest pharmacopoeia standard...

Embodiment 3

[0032] Add 6g of dexamethasone phosphate into a three-necked flask, add 50ml of methanol and 0.5g of activated carbon at the same time, stir and dissolve at a constant temperature of 45°C, and filter after continuous stirring for 60 minutes. The filtrate is moved into the crystallizer, and the sodium hydroxide solution of 250g / L is configured simultaneously. Then sodium hydroxide solution is added into the crystallizer for reaction, and the pH value at the end of the reaction process is controlled at 9.5. Add about 300 ml of ethanol-water mixed solvent to the reacted dexamethasone sodium phosphate solution while stirring at 20° C. to crystallize. After the crystallization is completed, carry out centrifugation, wash with ethanol, and dry the obtained crystal product at a temperature of 80° C. and a pressure of 0.1 MPa for 5 hours, and then at this temperature of 0.009 MPa for 10 hours. The content of the final crystal product is 99.4%, and the quality conforms to the latest p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The present invention is dexamethasone sodium phosphate crystal and its preparation process. The preparation process includes the following steps: mixing dexamethasone phosphate, alcohol solvent and active carbon in certain proportion in a reactor at 35-45 deg.c via stirring for 30-60 min, and filtering; transferring the filtrate into crystallizer, adding 100-250 g / L sodium hydroxide solution to react at constant temperature in 15-35 deg.c and controlling reaction terminal pH 9-12.5; adding separating agent in the amount of 2-6 times the solvent volume to crystallize after reaction; and centrifugal separating and drying at 40-80 deg.c and 0.002-0.1 MPa for 15-24 hr. Thus prepared crystal belongs to Pmc21 space group of orthorhombic system. The process has high crystal product quality and yield.

Description

technical field [0001] The invention belongs to the technical field of crystallization, and in particular relates to a crystal form of dexamethasone sodium phosphate and a crystallization preparation method thereof. Background technique [0002] The chemical name of dexamethasone sodium phosphate is 16α-methyl-11β,17α,21-trihydroxy-9α-fluoropregna-1,4-diene-3,20-dione-21- Phosphate disodium salt, molecular formula C 22 h 28 FO 8 PNa 2 , the molecular weight is 516.4, and its chemical structure is shown in Figure 1. [0003] Dexamethasone Sodium Phosphate is a kind of adrenal glucocorticoid drugs. It has stronger anti-inflammatory, anti-toxin and anti-shock effects, and has no sodium retention and potassium excretion effects. It is indispensable for rescuing critically ill patients. Emergency medicine, once known as the "king of corticosteroid drugs" in the 1970s. Its raw materials can be made into clinical injection injections, oral tablets and external preparations. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J7/00B01D9/00
Inventor 王静康王福军王永莉张美景郝红勋
Owner TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products